1.
Hong C, Kim S, Curnew G, Schulman S, Pullenayegum E, Holbrook A. VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION. J Popl Ther Clin Pharmacol. 2013;20(3). Accessed September 17, 2026. http://www.jptcp.com/index.php/jptcp/article/view/357